ProZyme: ProZyme, Inc. And Sign Licensing Agreement To Develop Gly-Q System For Glycan Analysis

HAYWARD, Calif.--(BUSINESS WIRE)--ProZyme, Inc., manufacturer of bioreagents for glycobiology, and BiOptic Inc. of Taiwan, manufacturer of instruments for DNA analysis by capillary gel electrophoresis (CGE), today announce an agreement to collaborate on the development and commercialization of an integrated system (Gly-Q) for high-throughput, user-friendly glycoanalysis. The Gly-Q collaboration will...